Showing results (431-440 of 547) with videos related to
Sort By:
Pageof 55
Chemistry & Biology|November 13, 2012
Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicityHao Li, Elizabeth L Ponder, Martijn Verdoes, et al.Circulation|January 27, 2018
Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological RemodelingRong-Rong Zhao, Matthew Ackers-Johnson, Justus Stenzig, et al.Chemistry & Biology|December 25, 2012
The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipainsSara Christina Stolze, Edgar Deu, Farnusch Kaschani, et al.Nature|February 12, 2016
Structure- and function-based design of Plasmodium-selective proteasome inhibitorsHao Li, Anthony J O'Donoghue, Wouter A van der Linden, et al.Scientific Reports|August 15, 2020
Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microgliaMaria A Telpoukhovskaia, Kai Liu, Faten A Sayed, et al.Methods in Molecular Biology (Clifton, N.J.)|October 16, 2016
Databases and Associated Tools for Glycomics and GlycoproteomicsFrederique Lisacek, Julien Mariethoz, Davide Alocci, et al.Glycobiology|September 22, 2007
Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgGRadka Saldova, Louise Royle, Catherine M Radcliffe, et al.Glycobiology|September 27, 2008
A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progressionUmi M Abd Hamid, Louise Royle, Radka Saldova, et al.Plos One|January 27, 2011
Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assaysMeital Cohen, Rami Yossef, Tamir Erez, et al.Scientific Reports|October 25, 2024
Endometriosis specific vaginal microbiota links to urine and serum N-glycomeJohn MacSharry, Zsuzsanna Kovács, Yongjing Xie, et al.Pageof 55